Yahoo Finance • 9 days ago
In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Bausch Health Companies is one of them. Bausch Health Companies Inc. (NYSE:BHC), a global specialty pharmaceutical company, has recently gained attent... Full story
Yahoo Finance • 14 days ago
(RTTNews) - Bausch Health Companies Inc. has successfully completed its tender offer to acquire DURECT Corporation (DRRX) for $1.75 per share in cash, totaling approximately $63 million upfront. The deal also includes up to $350 million i... Full story
Yahoo Finance • 27 days ago
We recently compiled a list of the 10 Overlooked Healthcare Stocks to Invest in. Bausch Health Companies Inc. is one of them. Bausch Health Companies Inc. (NYSE:BHC) is a global specialty pharmaceutical and medical device company focused... Full story
Yahoo Finance • 30 days ago
LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and DURECT Corporation (NASDAQ:DRRX) today announced that BHC Lyon Merger Sub... Full story
Yahoo Finance • last month
NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the... Full story
Yahoo Finance • 2 months ago
NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in th... Full story
Yahoo Finance • 2 months ago
DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy Designation Potential to be the first FDA-approved therapeutic option for the treatment of patients with alcoholic hepatitis Proposed acquisition... Full story
Yahoo Finance • 2 years ago
Participants Tim Papp; CFO; DURECT Corporation Jim Brown; CEO; DURECT Corporation François Brisebois; Analyst; Oppenheimer & Co, Inc. Carl Byrnes; Analyst; Northland Capital Markets Thomas Yip; Analyst; H.C. Wainwright & Co., LLC Pre... Full story